In recent years, microdosing has gained popularity as an alternative way to experience the effects of many substances, including MDMA, a drug commonly known as ecstasy or Molly. MDMA is celebrated for its effects that heighten feelings of love, connection, and euphoria and can lead to serious health risks and dependency issues that necessitate professional intervention. As research continues, MDMA is poised to become a powerful tool in the treatment of PTSD. While some may find benefits in the effects of microdosing MDMA, it doesn’t come without risks. Even a low dose can lead to something more concerning.
Understanding MDMA
MDMA (3,4-methylenedioxymethamphetamine) is a synthetic drug that acts as both a stimulant and psychedelic. According to the National Institute on Drug Abuse, MDMA produces an energizing effect, distortions in time and perception, and enhanced enjoyment of social experiences. The drug was originally developed to help control bleeding, but over time, it gained popularity in the recreational drug scene due to its pleasurable effects. MDMA affects a person’s mood by changing the release of chemicals in the body that affect mood and behavior.
Historical Context
MDMA was first synthesized in 1912 by the German pharmaceutical company Merck. Initially developed as a precursor to another drug, its psychoactive effects were not discovered until the 1970s. MDMA saw increased popularity in the 1980s as a recreational drug, particularly within the rave and clubbing scene.
How MDMA Works
MDMA works by increasing the levels of serotonin, dopamine, and norepinephrine in the brain. Serotonin regulates mood, while dopamine and norepinephrine are associated with pleasure and arousal. MDMA also enhances the therapeutic relationship, making individuals more comfortable discussing difficult topics. The pharmacologic effects of MDMA involve the release of neurotransmitters such as serotonin, dopamine, and norepinephrine, with a subsequent increased secretion of several hormones such as oxytocin, prolactin, cortisol, and vasopressin.
Recreational vs. Therapeutic Use
MDMA is often seen in social settings like parties and music festivals. As of 2021, around 21.1 million people in the United States had used MDMA at some point in their lifetime. However, it’s essential to distinguish between recreational use and therapeutic applications of MDMA. Recreational use often involves higher doses and unpredictable environments, increasing the risk of adverse effects. Therapeutic use, on the other hand, involves controlled doses of pure MDMA administered under professional supervision in a safe clinical setting.
Read also: Summit Chiropractic: Holistic wellness solutions.
Microdosing MDMA
Microdosing involves taking a low dose of a substance to achieve subtle, often healing effects instead of a high. This avoids the intense highs or hallucinations associated with a full dose.
Effects of Microdosing
When someone microdoses MDMA, they aim to experience the potential medicinal benefits of the drug without the overwhelming effects of a standard recreational dose. A full dose of MDMA can cause intense euphoria, heightened senses, and emotional openness. The effects of microdosing MDMA can lead to subtle feelings that are not overwhelming. Some people report increased sociability, improved mood, heightened sensory perception, and enhanced empathy. However, these effects are generally less notable than those experienced with a full dose of MDMA. Some use microdosing to help with stress disorders. Post-traumatic stress disorder is one such stress disorder (PTSD).
Risks of Microdosing
Even a low dose of MDMA can lead to concerning outcomes. As with all illicit street drugs, the strength and duration of MDMA can vary from one dose to the next. Without safety regulations and quality control, people who buy MDMA (and even those who sell it) don’t always know exactly what they’re getting. MDMA has the potential for psychological dependence, although it is considered to be less addictive than some other drugs, such as opioids or stimulants like cocaine.
Guided MDMA Therapy: A Promising Treatment
MDMA-assisted psychotherapy is a type of therapy that has gained attention in recent years due to its potential to help individuals with certain mental health conditions. The therapy session typically lasts around eight hours, with the individual lying down and wearing an eye mask and headphones. During the therapy session, the individual may experience a range of emotions, from euphoria to anxiety. The therapist helps the individual navigate these emotions and encourages them to explore their thoughts and feelings. The use of MDMA in therapy enhances communication, which can result in the discovery of previously unexpressed thoughts and emotions. The therapist helps the individual integrate their experience with the drug into their overall therapeutic journey.
How It Works
MDMA-assisted psychotherapy involves ingesting 120 mg of MDMA, followed by an optional half-dose of 40 mg administered about two hours after the initial dose to extend the therapeutic effects. The effects can last as long as eight hours, during which the patient has the opportunity to revisit important past events and emotions with two trained therapists. Preparation and integration sessions help the patient consolidate therapeutic gains. MDMA’s effect on the brain also includes the release of hormones like oxytocin and prolactin, which foster a sense of bonding and decrease the emotional distance between the therapist and the patient. This improves the therapeutic alliance-an essential element in any psychotherapy setting.
Read also: Benefits of Foot Massage in Pleasanton
The Therapeutic Process
Guided MDMA Therapy involves a structured, patient-centered approach that is meticulously designed to foster a safe and effective healing environment.
- Preparation Phase: Before the actual administration of MDMA, patients undergo thorough preparatory sessions. These sessions aim to build trust and rapport between the patient and the therapist, set treatment goals, and educate the patient about what to expect during and after the therapy.
- MDMA Sessions: During the guided MDMA therapy sessions, patients are administered a carefully measured dose of MDMA in a calm, controlled clinical setting. Once the effects of MDMA commence, patients experience an enhanced state of openness and reduced fear responses, which facilitates deeper emotional engagement with traumatic memories. The therapist guides the process, encouraging the patient to explore their feelings and thoughts that arise during the session. The setting for these sessions is carefully prepared to promote relaxation and safety. Participants often describe the setting as calm and comforting, akin to a “spa,” which helps in fostering a sense of safety and openness. The presence of trained therapists who guide the session with a non-directive approach allows participants to explore their emotions deeply.
- Integration Phase: Post-session integration is vital. In this phase, patients meet with their therapist several times to discuss and make sense of the thoughts and emotions that emerged during the MDMA sessions. This phase helps patients consolidate their insights and learn how to apply these new perspectives to their daily lives.
Clinical Evidence
The efficacy of guided MDMA therapy in treating PTSD and other severe mental health disorders has been supported by robust clinical research. A series of Phase 3 clinical trials have been pivotal in establishing the therapeutic credentials of MDMA. For instance, a multi-site study led by the University of California, San Francisco (UCSF), demonstrated significant benefits of MDMA-assisted therapy. In this study, participants with moderate to severe PTSD showed approximately double the rates of recovery compared to those who received a placebo. Another critical aspect of these studies is the long-term efficacy of the treatment. The Mitchell study, for example, reported that 86.5% of participants experienced clinically meaningful benefits, with significant reductions in PTSD symptoms sustained over time. MDMA-assisted psychotherapy has demonstrated greater therapeutic efficacy than any other psychotherapy or medication for PTSD. Unlike with many other therapies for PTSD, symptom reduction can be maintained after a single course of treatment by most patients. And the effects last-more than two-thirds of patients receiving MDMA-assisted psychotherapy no longer had PTSD when measured one year later.
Personal Testimonials
Personal testimonials from individuals who have participated in guided MDMA therapy sessions reveal profound and often life-changing benefits. One striking narrative comes from a participant identified as Nathan McGee, who described his MDMA therapy experience as opening a new window to joy and self-understanding that he had not felt in years. He detailed sessions that were both introspective and liberating, allowing him to revisit traumatic memories without the typical emotional turmoil. The impact of guided MDMA therapy extends beyond the immediate aftermath of the sessions. Many participants report lasting changes in their approach to personal relationships and daily stressors. Improvements in symptoms are not just transient; participants often experience enduring relief from PTSD symptoms, which significantly enhances their overall quality of life.
Benefits of MDMA-Assisted Psychotherapy
- Early research found that MDMA-assisted therapy produced lasting benefits in patients with PTSD, depression, and anxiety.
- One study published in the Journal of Psychopharmacology found that MDMA-assisted psychotherapy was effective in reducing symptoms of PTSD in veterans.
- Recent clinical trials have shown promising results in the use of MDMA-assisted psychotherapy as a treatment for depression.
- MDMA enhances communication, which can result in the discovery of previously unexpressed thoughts and emotions.
Risks and Side Effects
MDMA-assisted therapy should always be conducted in a safe and controlled environment, administered by trained professionals and in compliance with legal regulations. Individuals with certain medical conditions, such as heart disease or high blood pressure, may be at increased risk for adverse reactions to MDMA. While MDMA is generally well-tolerated, it does have potential side effects such as nausea, headaches, and fatigue, which are typically transient and manageable under clinical supervision.
Serotonin Toxicity
Taking MDMA alongside antidepressants can also cause dangerous side effects. Combining MDMA with some antidepressants may increase the risk of toxicity from an excess of serotonin. Symptoms include confusion, agitation, very high temperature, and potential coma and death.
Read also: Sports Massage for Two
Psychological Risks
MDMA may increase feelings of distress in people with a history of mental illness. More serious concerns include the risk of misuse and the psychological impact of intense emotional experiences triggered during therapy.
Legal and Ethical Considerations
Despite its potential therapeutic benefits, MDMA is a Schedule I drug, meaning it has a high potential for abuse and no currently accepted medical use. Overcoming the stigma associated with MDMA's recreational use is crucial for its acceptance as a therapeutic option. Education and awareness campaigns are essential to inform the public about the differences between medical and recreational use of MDMA.
Path to Legalization
The path to reclassification and approval by the FDA requires extensive evidence of both efficacy and safety, gathered through rigorous clinical trials. Food and Drug Administration (FDA) designated MDMA-assisted psychotherapy as a breakthrough therapy. Expanded access status was granted in 2020 in the United States and Israel. MDMA itself is not officially legal or approved for clinical use, but phase III trials are underway.
Alternatives to MDMA
There are various traditional and alternative depression treatments available. Traditional depression treatments include psychotherapy (such as cognitive behavioral therapy or CBT), medications (such as antidepressants and mood stabilizers), regular exercise, mindfulness and meditation, high-quality sleep, stress reduction techniques and practices, brain stimulation therapies (such as electroconvulsive therapy), and light therapy to regulate melatonin production. People can work alongside a healthcare professional to develop a personalized treatment plan that is safe and effective for them.
Other drugs, such as psychedelics, are also being researched for their potential to treat depression. A 2016 study looked at the effects of psilocybin, a hallucinogenic substance in some types of mushrooms. The researchers gave each participant a 10-milligram (mg) and a 25-mg oral dose of psilocybin, 7 days apart. There was a decrease in initial depression scores at 1 week and 3 months after treatment, with the biggest reduction taking place in the second week of the trial. Eight of the 12 participants had complete remission in week one, and seven of these individuals had continued remission 3 months later. None of the participants experienced unexpected or serious side effects. Microdosing psychedelics such as lysergic acid diethylamide (LSD) and psilocybin is another area of research. Anecdotal reports suggest that microdosing can improve mood, social ability, and overall well-being.
Finding Help
If you or someone you know is struggling with a dependence on MDMA, don’t hesitate to reach out to one of our addiction treatment and mental health treatment facilities for help. There are resources available to guide you on the path to recovery.